November
Medicinal Chemistry
Strategy Meeting East Coast USA 2022
Reinvigorating Productivity in Pharma & Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our 2022 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Dr. Tao Guo
SVP and Head of WuXi Chemistry – Research Chemistry Services Business Development and Integrated Program Management WuXi AppTec
Andreas Schoops
Head of Medicinal Chemistry WuXi AppTec
Greg Makara
CEO ChemPass
Onur Atasoylu
Director, Head of Computational Chemistry Incyte
Matt Bursavich
Vice President, Head of Chemical Sciences Morphic Therapeutic
Heather Carlson
Vice President Chemical Data Sciences Odyssey Therapeutics
Rich Heidebrecht
Vice President of Research and Development Glycologix
Jason Imbriglio
Vice President, Head of Discovery Chemistry Roivant Discovery
Kevin Kreutter
Vice President, Drug Discovery Empress Therapeutics
Stephanos Loannidis
EVP Drug Discovery Exo Therapeutics
Kristen Marino
Senior Scientist II, Computational Chemistry Cellarity
Andrew McRiner
Vice President, Head of Drug Discovery Auron Therapeutics
Benoit Moreau
Head of Medicinal Chemistry Remix Therapeutics
Robb Nicewonger
Senior Director, Medicinal Chemistry Cellarity
Ed Olhava
Senior Vice President, Preclinical Development IFM Therapeutics
Lewis Pennington
Senior Director. Head of Platform Chemistry Kymera Therapeutics
Nisha Perez
Senior Director, Head of DMPK ROME Therapeutics
Jennifer Petter
Founder & CSO Arrakis Therapeutics
Daniel J. Price
Executive Director, Head of Computational Chemistry Nimbus Therapeutics
Aimee Usera
Vice President Chemistry Odyssey TherapeuticsSee the full agenda and facilitator line-up
Download the strategy meeting brochure for full detailsWho Should Attend the Event?
Chief Executive Officers
Executive Vice Presidents
Vice Presidents
Executive Directors
Directors
Global Heads
Responsible For:
Medicinal Chemist
Computational Chemist
Translational
Chemist/Biology
In-Silico/In-vivo/In-vitro Chemist/Biologist
Chemical Biology
Molecular Chemist/Biologist
Hit and Lead Chemist
Small/Large Molecules Chemist
Drug Discovery or Drug Development
See Which Topics Are Discussed at the Strategy Meeting
Advantages and Limitations in Targeting RNA with Small Molecules
Roundtable Tracks
1Roundtable Tracks
2Strategy and Implementation for Innovative and Emerging Modalities Drug Discovery WUXI APPTEC
Hit Identification Technologies and Cracking Undruggable Targets – Which Technology to Choose? WUXI APPTEC
Reasons To Attend the Strategy Meeting

Discussions on the advancements in targeted protein degradation and pushing past its boundaries.





Leveraging Artificial Intelligence and Machine Learning in accelerating the development of new drugs





Discuss approaches to further understand the interactions of undruggable targets and different Protein Degraders such as PROTACs, Molecular Glues, etc





Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more






Press play to hear what your colleagues had to say…
Become an official strategy meeting partner
Whatever your business needs, we can help. Get in touch for partnering opportunitiesHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.
Want to find out more?
Find out more details about our Strategy Meetings and other news and events.